官方服务：
资源简介：
Oxaliplatin resistance in gastric cancer
应用场景：
创建时间：
2020-10-19
相关数据集
Carboplatin: molecular mechanisms of action associated with chemoresistance
Carboplatin is a derivative of cisplatin; it has a similar mechanism of action, but differs in terms of structure and toxicity. It was approved by the FDA in the 1980s and since then it has been widel
DataCite Commons2022-06-09 更新100
miR-200b is associated with cisplatin sensitivity in bladder cancer cells
We aimed to clarify the role of miR-200b in cisplatin (CDDP) sensitivity in bladder cancer (BCa). CDDP resistant T24 cells (T24RC) were transfected with a miR mimic negative control (NC) or a miR-200b
NIAID Data Ecosystem70
Additional file 4: of Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines
The top 50 overexpressed genes in the SN-38 resistant MCF7 cells. (XLSX 62Â kb)
NIAID Data Ecosystem40
Additional file 4 of Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism
Additional file 4: Table S4. Details of DEGs obtained by GO enrichment analysis (biological process, cellular component, molecular function). Note: KS, Kolmogorov–Smirnov.
DataCite Commons2024-02-23 更新90
North America Oxaliplatin for Injection Market
North America Oxaliplatin for Injection comes with extensive industry analysis of development components, patterns, flows, and sizes. The report calculates present and past market values to forecast p
IMR REPORTS60
